drugset / Trial / NCT03315000
Effect of Vilanterol on Methacholine Challenge Results
RandomizedCrossoverTriple-blindTreatment
Summary
The study will assess the degree of bronchoprotection provided by the ultra long-acting beta2 agonist vilanterol against methacholine-induced bronchoconstriction.
Timeline
- Start
- 2017-10-13
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone Furoate | Other / unclassified | 100 ug | Inhaled |
| Subject | Vilanterol | Other / unclassified | 25 ug | Inhaled |